FDA warns CalmCo that Colic Calm and Colic Calm + are unapproved new drugs for infants.
What happened
FDA reviewed www.coliccalm.com in May 2023 and the product labels. FDA found that CalmCo offers Colic Calm and Colic Calm + for sale with claims to relieve infant colic, gas, reflux, upset stomach, bloating, and hiccups. FDA determined the products are unapproved new drugs because no approved application is in effect and they are not generally recognized as safe and effective for those uses; the letter also cites a related CGMP (current good manufacturing practice) warning letter to Denison Pharmaceuticals.
What FDA found
FDA says Colic Calm and Colic Calm + are unapproved new drugs because they are intended to treat infant colic, gas, reflux, and related symptoms and no FDA-approved application is in effect.
FD&C Act §§ 505(a), 301(d), 201(p); 21 U.S.C. 355(a), 331(d), 321(p)The product labels and website claims show the products are intended to cure, mitigate, treat, or prevent disease or affect body function, making them drugs.
FD&C Act § 201(g)(1), 21 U.S.C. 321(g)(1)Labeling the products as homeopathic does not exempt them from the same drug approval, adulteration, and misbranding requirements.
FD&C Act § 201(g)(1), 21 U.S.C. 321(g)(1)
What FDA wants
FDA asks CalmCo to notify it in writing within 15 working days of the steps taken to correct the violations and prevent recurrence, with supporting documentation. If CalmCo believes the products are not in violation, it must include its reasoning and supporting information.
Who should pay attention
- parents and caregivers of infants
- retailers and online sellers of infant gripe water
- contract manufacturers and brands of homeopathic infant drugs
This is a summary. Read the original letter on fda.gov.